Loading...

Media

PUBLICATIONS

Volatile organic compounds (VOC)-based probes for predicting the efficacy of targeted chemotherapies

Targeting the tumor microenvironment hallmarks for pancreas and breast (TN) cancers chemotherapy

ADCs with high Drug Antibody Ratio

β-Galactosidase-responsive ADC for breast (HER2+) cancer chemotherapy

Small molecular weight drug delivery system to treat head and neck cancers

NEWS

SEEKYO: A major advance against Cancer fight

SEEKYO: A major advance against Cancer fight

SEEKYO and the DeepTech – BPI

SEEKYO and the DeepTech – BPI

SEEKYO certified Onco-Entrepreneur

SEEKYO certified Onco-Entrepreneur

SEEKYO certified French Tech Seed

SEEKYO certified French Tech Seed

INFO ECO presents SEEKYO

INFO ECO presents SEEKYO

University of Poitiers presents SEEKYO

University of Poitiers presents SEEKYO

SEEKYO is awarded laureate of GENOPOLE Booster program

SEEKYO is awarded laureate of GENOPOLE Booster program

SEEKYO – the inception

SEEKYO – the inception

EVENTS

BIOFIT 2019 (Marseille, France).

BIOFIT 2019 (Marseille, France).

BIO USA 2019 (Philadelphia,USA).

BIO USA 2019 (Philadelphia,USA).

MEET2WIN (Bordeaux,France).

MEET2WIN (Bordeaux,France).

BIO-EUROPE 2018 (Copenhagen, Denmark).

BIO-EUROPE 2018 (Copenhagen, Denmark).

54th International Conference on Medicinal Chemistry

54th International Conference on Medicinal Chemistry

6th Antibody Industrial Symposium 2018

6th Antibody Industrial Symposium 2018